Home LiteratureArticle Details
PMID: 17602953 Published · ppublish English Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

6-Hydroxydopamine induces mitochondrial ERK activation.

Free radical biology & medicine ·Vol. 43 ·No. 3 ·2007-08-01 ·Pages 372-83

Kulich SM, Horbinski C, Patel M, Chu CT

Abstract

Reactive oxygen species (ROS) are implicated in 6-hydroxydopamine (6-OHDA) injury to catecholaminergic neurons; however, the mechanism(s) are unclear. In addition to ROS generated during autoxidation, 6-OHDA may initiate secondary cellular sources of ROS that contribute to toxicity. Using a neuronal cell line, we found that catalytic metalloporphyrin antioxidants conferred protection if added 1 h after exposure to 6-OHDA, whereas the hydrogen peroxide scavenger catalase failed to protect if added more than 15 min after 6-OHDA. There was a temporal correspondence between loss of protection and loss of the ability of the antioxidant to inhibit 6-OHDA-induced ERK phosphorylation. Time course studies of aconitase inactivation, an indicator of intracellular superoxide, and MitoSOX red, a mitochondria targeted ROS indicator, demonstrate early intracellular ROS followed by a delayed phase of mitochondrial ROS production, associated with phosphorylation of a mitochondrial pool of ERK. Furthermore, on initiation of mitochondrial ROS and ERK activation, 6-OHDA-injured cells became refractory to rescue by metalloporphyrin antioxidants. Together with previous studies showing that inhibition of the ERK pathway confers protection from 6-OHDA toxicity, and that phosphorylated ERK accumulates in mitochondria of degenerating human Parkinson's disease neurons, these studies implicate mitochondrial ERK activation in Parkinsonian oxidative neuronal injury.

MeSH Terms
Animals Butadienes/pharmacology Catalase/pharmacology Cells, Cultured Enzyme Activation Extracellular Signal-Regulated MAP Kinases/physiology Flavonoids/pharmacology Metalloporphyrins/pharmacology Mitochondria/drug effects,physiology Mitogen-Activated Protein Kinase Kinases/antagonists & inhibitors Neurons/drug effects Nitriles/pharmacology Oxidopamine/pharmacology,toxicity Rats Signal Transduction
Chemicals
Butadienes Flavonoids Metalloporphyrins Nitriles U 0126 manganese (III) meso-tetrakis(N-ethylpyridinium-2-yl)porphyrin manganese(III)-tetrakis(4-benzoic acid)porphyrin Oxidopamine Catalase Extracellular Signal-Regulated MAP Kinases Mitogen-Activated Protein Kinase Kinases 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Kulich Scott M
Department of Pathology, VA Pittsburgh Healthcare System, Pittsburgh, PA 15240, USA. kulichsm@upmc.edu
Horbinski Craig
Patel Manisha
Chu Charleen T
References (81)
81 references, click to expand
  1. Manganic porphyrins possess catalase activity and protect endothelial cells against hydrogen peroxide-mediated injury.
    Arch Biochem Biophys. 1997 Nov 15;347(2):256-62 PMID: 9367533
  2. Role of extracellular signal-regulated protein kinases in apoptosis by asbestos and H2O2.
    Am J Physiol. 1997 Nov;273(5 Pt 1):L1029-35 PMID: 9374731
  3. Peroxynitrite decomposition catalysts: therapeutics for peroxynitrite-mediated pathology.
    Proc Natl Acad Sci U S A. 1998 Mar 3;95(5):2659-63 PMID: 9482943
  4. The regulation of reactive oxygen species production during programmed cell death.
    J Cell Biol. 1998 Jun 15;141(6):1423-32 PMID: 9628898
  5. Attenuation of 6-hydroxydopamine-induced dopaminergic nigrostriatal lesions in superoxide dismutase transgenic mice.
    Neuroscience. 1998 Aug;85(3):907-17 PMID: 9639283
  6. Parkinson's disease. First of two parts.
    N Engl J Med. 1998 Oct 8;339(15):1044-53 PMID: 9761807
  7. Distinct mechanisms underlie neurotoxin-mediated cell death in cultured dopaminergic neurons.
    J Neurosci. 1999 Feb 15;19(4):1284-93 PMID: 9952406
  8. Dopamine oxidation alters mitochondrial respiration and induces permeability transition in brain mitochondria: implications for Parkinson's disease.
    J Neurochem. 1999 Sep;73(3):1127-37 PMID: 10461904
  9. Metalloporphyrin class of therapeutic catalytic antioxidants.
    Trends Pharmacol Sci. 1999 Sep;20(9):359-64 PMID: 10462758
  10. Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology.
    Neuron. 2004 Nov 18;44(4):601-7 PMID: 15541309
  11. Kinase signaling cascades in the mitochondrion: a matter of life or death.
    Free Radic Biol Med. 2005 Jan 1;38(1):2-11 PMID: 15589366
  12. Effects of 6-hydroxydopamine on mitochondrial function and glutathione status in SH-SY5Y human neuroblastoma cells.
    Toxicol In Vitro. 2005 Jun;19(4):471-9 PMID: 15826805
  13. Manganese superoxide dismutase protects against 6-hydroxydopamine injury in mouse brains.
    J Biol Chem. 2005 May 6;280(18):18536-42 PMID: 15755737
  14. Reactive oxygen and nitrogen species: weapons of neuronal destruction in models of Parkinson's disease.
    Antioxid Redox Signal. 2005 May-Jun;7(5-6):685-93 PMID: 15890013
  15. NADPH oxidase is required for NMDA receptor-dependent activation of ERK in hippocampal area CA1.
    J Neurochem. 2005 Jul;94(2):299-306 PMID: 15998281
  16. Superoxide dismutase/catalase mimetics are neuroprotective against selective paraquat-mediated dopaminergic neuron death in the substantial nigra: implications for Parkinson disease.
    J Biol Chem. 2005 Aug 12;280(32):29194-8 PMID: 15946937
  17. Reactive oxidative and nitrogen species in the nigrostriatal system following striatal 6-hydroxydopamine lesion in rats.
    Brain Res. 2005 Aug 2;1052(1):97-104 PMID: 16005444
  18. Dependence of excitotoxic neurodegeneration on mitochondrial aconitase inactivation.
    J Neurochem. 2001 Aug;78(4):746-55 PMID: 11520895
  19. Aconitase: sensitive target and measure of superoxide.
    Methods Enzymol. 2002;349:9-23 PMID: 11912933
  20. Mitochondrial cyclic AMP response element-binding protein (CREB) mediates mitochondrial gene expression and neuronal survival.
    J Biol Chem. 2005 Dec 9;280(49):40398-401 PMID: 16207717
  21. Stress-induced alterations in parkin solubility promote parkin aggregation and compromise parkin's protective function.
    Hum Mol Genet. 2005 Dec 15;14(24):3885-97 PMID: 16278233
  22. Expanding insights of mitochondrial dysfunction in Parkinson's disease.
    Nat Rev Neurosci. 2006 Mar;7(3):207-19 PMID: 16495942
  23. 6-hydroxydopamine-induced apoptosis is mediated via extracellular auto-oxidation and caspase 3-dependent activation of protein kinase Cdelta.
    J Biol Chem. 2006 Mar 3;281(9):5373-82 PMID: 16361258
  24. 6-Hydroxydopamine but not 1-methyl-4-phenylpyridinium abolishes alpha-synuclein anti-apoptotic phenotype by inhibiting its proteasomal degradation and by promoting its aggregation.
    J Biol Chem. 2006 Apr 7;281(14):9824-31 PMID: 16464850
  25. Superoxide anions and hydrogen peroxide induce hepatocyte death by different mechanisms: involvement of JNK and ERK MAP kinases.
    J Hepatol. 2006 May;44(5):918-29 PMID: 16310883
  26. Activation of mitogen-activated protein kinases by lysophosphatidylcholine-induced mitochondrial reactive oxygen species generation in endothelial cells.
    Am J Pathol. 2006 May;168(5):1737-48 PMID: 16651638
  27. Functional repression of cAMP response element in 6-hydroxydopamine-treated neuronal cells.
    J Biol Chem. 2006 Jun 30;281(26):17870-81 PMID: 16621793
  28. Mitochondrial pathology and muscle and dopaminergic neuron degeneration caused by inactivation of Drosophila Pink1 is rescued by Parkin.
    Proc Natl Acad Sci U S A. 2006 Jul 11;103(28):10793-8 PMID: 16818890
  29. Activation of ERK1/2 pathway mediates oxidant-induced decreases in mitochondrial function in renal cells.
    Am J Physiol Renal Physiol. 2006 Oct;291(4):F840-55 PMID: 16705147
  30. 6-Hydroxydopamine increases ubiquitin-conjugates and protein degradation: implications for the pathogenesis of Parkinson's disease.
    Cell Mol Neurobiol. 2001 Dec;21(6):771-81 PMID: 12043847
  31. Mitochondrial K(ATP) channel openers activate the ERK kinase by an oxidant-dependent mechanism.
    Am J Physiol Cell Physiol. 2002 Jul;283(1):C273-81 PMID: 12055096
  32. MPP+ increases alpha-synuclein expression and ERK/MAP-kinase phosphorylation in human neuroblastoma SH-SY5Y cells.
    Brain Res. 2002 May 10;935(1-2):32-9 PMID: 12062470
  33. Age-dependent decline of DNA repair activity for oxidative lesions in rat brain mitochondria.
    J Neurochem. 2002 Jun;81(6):1273-84 PMID: 12068075
  34. Effects of metalloporphyrin catalytic antioxidants in experimental brain ischemia.
    Free Radic Biol Med. 2002 Oct 1;33(7):947-61 PMID: 12361805
  35. Mechanistic approaches to Parkinson's disease pathogenesis.
    Brain Pathol. 2002 Oct;12(4):499-510 PMID: 12408237
  36. Cytoplasmic aggregates of phosphorylated extracellular signal-regulated protein kinases in Lewy body diseases.
    Am J Pathol. 2002 Dec;161(6):2087-98 PMID: 12466125
  37. Autoxidation of extracellular hydroquinones is a causative event for the cytotoxicity of menadione and DMNQ in A549-S cells.
    Arch Biochem Biophys. 2003 Mar 1;411(1):145-57 PMID: 12590933
  38. Role of reactive oxygen species in extracellular signal-regulated protein kinase phosphorylation and 6-hydroxydopamine cytotoxicity.
    J Biosci. 2003 Feb;28(1):83-9 PMID: 12682429
  39. NADPH oxidase mediates oxidative stress in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease.
    Proc Natl Acad Sci U S A. 2003 May 13;100(10):6145-50 PMID: 12721370
  40. Role of redox signaling in the autonomous proliferative response of endothelial cells to hypoxia.
    Circ Res. 2003 May 16;92(9):1010-5 PMID: 12690038
  41. Caspase-dependent and -independent cell death pathways in primary cultures of mesencephalic dopaminergic neurons after neurotoxin treatment.
    J Neurosci. 2003 Jun 15;23(12):5069-78 PMID: 12832530
  42. Localization of phosphorylated ERK/MAP kinases to mitochondria and autophagosomes in Lewy body diseases.
    Brain Pathol. 2003 Oct;13(4):473-81 PMID: 14655753
  43. Apoptosis inducing factor mediates caspase-independent 1-methyl-4-phenylpyridinium toxicity in dopaminergic cells.
    J Neurochem. 2005 Sep;94(6):1685-95 PMID: 16156740
  44. Mitochondrial import and enzymatic activity of PINK1 mutants associated to recessive parkinsonism.
    Hum Mol Genet. 2005 Nov 15;14(22):3477-92 PMID: 16207731
  45. Antioxidants protect PINK1-dependent dopaminergic neurons in Drosophila.
    Proc Natl Acad Sci U S A. 2006 Sep 5;103(36):13520-5 PMID: 16938835
  46. Parkinsonism genes: culprits and clues.
    J Neurochem. 2006 Nov;99(4):1062-72 PMID: 16836655
  47. Mitochondriopathy in Parkinson disease and amyotrophic lateral sclerosis.
    J Neuropathol Exp Neurol. 2006 Dec;65(12):1103-10 PMID: 17146283
  48. Localization of LRRK2 to membranous and vesicular structures in mammalian brain.
    Ann Neurol. 2006 Nov;60(5):557-69 PMID: 17120249
  49. Regulation of autophagy by extracellular signal-regulated protein kinases during 1-methyl-4-phenylpyridinium-induced cell death.
    Am J Pathol. 2007 Jan;170(1):75-86 PMID: 17200184
  50. Expression of Nrf2 in neurodegenerative diseases.
    J Neuropathol Exp Neurol. 2007 Jan;66(1):75-85 PMID: 17204939
  51. Mitochondria mass is low in mouse substantia nigra dopamine neurons: implications for Parkinson's disease.
    Exp Neurol. 2007 Feb;203(2):370-80 PMID: 17010972
  52. Extracellular toxicity of 6-hydroxydopamine on PC12 cells.
    Neurosci Lett. 2000 Apr 14;283(3):193-6 PMID: 10754220
  53. 6-Hydroxydopamine toxicity towards human SH-SY5Y dopaminergic neuroblastoma cells: independent of mitochondrial energy metabolism.
    J Neural Transm (Vienna). 2000;107(3):281-93 PMID: 10821437
  54. Estimation of H2O2 gradients across biomembranes.
    FEBS Lett. 2000 Jun 16;475(2):121-6 PMID: 10858501
  55. Delayed mitochondrial dysfunction in excitotoxic neuron death: cytochrome c release and a secondary increase in superoxide production.
    J Neurosci. 2000 Aug 1;20(15):5715-23 PMID: 10908611
  56. Activation of JNK, p38 and ERK mitogen-activated protein kinases by chromium(VI) is mediated through oxidative stress but does not affect cytotoxicity.
    Carcinogenesis. 2000 Aug;21(8):1491-500 PMID: 10910949
  57. Mitochondrial superoxide production in kainate-induced hippocampal damage.
    Neuroscience. 2000;101(3):563-70 PMID: 11113305
  58. Different accumulation of activated extracellular signal-regulated kinases (ERK 1/2) and role in cell-cycle alterations by epidermal growth factor, hydrogen peroxide, or asbestos in pulmonary epithelial cells.
    Am J Respir Cell Mol Biol. 2001 Apr;24(4):405-13 PMID: 11306433
  59. Sustained extracellular signal-regulated kinase activation by 6-hydroxydopamine: implications for Parkinson's disease.
    J Neurochem. 2001 May;77(4):1058-66 PMID: 11359871
  60. Enhanced substantia nigra mitochondrial pathology in human alpha-synuclein transgenic mice after treatment with MPTP.
    Exp Neurol. 2004 Apr;186(2):158-72 PMID: 15026254
  61. Mitochondrial extracellular signal-regulated kinases 1/2 (ERK1/2) are modulated during brain development.
    J Neurochem. 2004 Apr;89(1):248-56 PMID: 15030409
  62. Bcl-x L blocks mitochondrial multiple conductance channel activation and inhibits 6-OHDA-induced death in SH-SY5Y cells.
    J Neurochem. 2004 Apr;89(1):124-33 PMID: 15030396
  63. The role of oxidative stress, impaired glycolysis and mitochondrial respiratory redox failure in the cytotoxic effects of 6-hydroxydopamine in vitro.
    Brain Res. 2004 Apr 9;1004(1-2):29-44 PMID: 15033417
  64. Oxidative neuronal injury. The dark side of ERK1/2.
    Eur J Biochem. 2004 Jun;271(11):2060-6 PMID: 15153095
  65. Bile acids induce mitochondrial ROS, which promote activation of receptor tyrosine kinases and signaling pathways in rat hepatocytes.
    Hepatology. 2004 Oct;40(4):961-71 PMID: 15382121
  66. 6-Hydroxy-dopamine induced degeneration of central monoamine neurons.
    Eur J Pharmacol. 1968 Dec;5(1):107-10 PMID: 5718510
  67. The generation of hydrogen peroxide, superoxide radical, and hydroxyl radical by 6-hydroxydopamine, dialuric acid, and related cytotoxic agents.
    J Biol Chem. 1974 Apr 25;249(8):2447-52 PMID: 4362682
  68. Clonal cell lines from the rat central nervous system.
    Nature. 1974 May 17;249(454):224-7 PMID: 4151463
  69. Catalase in vitro.
    Methods Enzymol. 1984;105:121-6 PMID: 6727660
  70. Mitochondrial complex I deficiency in Parkinson's disease.
    Lancet. 1989 Jun 3;1(8649):1269 PMID: 2566813
  71. Deficiencies in complex I subunits of the respiratory chain in Parkinson's disease.
    Biochem Biophys Res Commun. 1989 Sep 29;163(3):1450-5 PMID: 2551290
  72. Abnormalities of the electron transport chain in idiopathic Parkinson's disease.
    Ann Neurol. 1989 Dec;26(6):719-23 PMID: 2557792
  73. Sustained activation of the mitogen-activated protein (MAP) kinase cascade may be required for differentiation of PC12 cells. Comparison of the effects of nerve growth factor and epidermal growth factor.
    Biochem J. 1992 Dec 1;288 ( Pt 2):351-5 PMID: 1334404
  74. The determination of hydroxydopamines and other trace amines in the urine of parkinsonian patients and normal controls.
    Neurochem Res. 1993 Nov;18(11):1175-7 PMID: 8255370
  75. EGF triggers neuronal differentiation of PC12 cells that overexpress the EGF receptor.
    Curr Biol. 1994 Aug 1;4(8):694-701 PMID: 7953555
  76. PC12 cells overexpressing the insulin receptor undergo insulin-dependent neuronal differentiation.
    Curr Biol. 1994 Aug 1;4(8):702-8 PMID: 7953556
  77. Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation.
    Cell. 1995 Jan 27;80(2):179-85 PMID: 7834738
  78. Inhibition of mitochondrial complexes I and IV by 6-hydroxydopamine.
    Eur J Pharmacol. 1995 Mar 16;292(3-4):329-32 PMID: 7796873
  79. Nature of inhibition of mitochondrial respiratory complex I by 6-Hydroxydopamine.
    J Neurochem. 1996 May;66(5):2004-10 PMID: 8780029
  80. Reactive dopamine metabolites and neurotoxicity: implications for Parkinson's disease.
    Adv Exp Med Biol. 1996;387:97-106 PMID: 8794199
  81. Unlike MPP+, apoptosis induced by 6-OHDA in PC12 cells is independent of mitochondrial inhibition.
    Neurosci Lett. 1996 Dec 27;221(1):69-71 PMID: 9014183
Article Info
Journal
Free radical biology & medicine
Abbr.
Free Radic Biol Med
ISSN
0891-5849
Published
2007-08-01
Epub
2007-00-29
Pages
372-83
Language
English
Region
United States
NLM ID
8709159
PMCID
PMC2023873
Subset
IM
Grants
NINDS NIH HHS · NS053777 · United States
NINDS NIH HHS · R01 NS045748-04 · United States
NIA NIH HHS · AG026389 · United States
NIA NIH HHS · R01 AG026389-01A2 · United States
NINDS NIH HHS · R21 NS053777-02 · United States
NINDS NIH HHS · NS045748 · United States
NINDS NIH HHS · R01 NS040817 · United States
NINDS NIH HHS · NS40817 · United States
NINDS NIH HHS · R01 NS040817-04 · United States
NIA NIH HHS · R01 AG026389 · United States
NINDS NIH HHS · R21 NS053777 · United States
NINDS NIH HHS · R01 NS045748 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com